R1	Has_qualifier Arg1:T7 Arg2:T8	
*	OR T11 T12 T10
R2	Has_temporal Arg1:T2 Arg2:T11	
R3	Has_temporal Arg1:T15 Arg2:T17	
R4	Has_value Arg1:T15 Arg2:T16	
R5	Has_temporal Arg1:T19 Arg2:T18	
R6	Has_index Arg1:T22 Arg2:T23	
R7	Has_negation Arg1:T21 Arg2:T24	
R8	Has_temporal Arg1:T21 Arg2:T22	
R9	Has_negation Arg1:T16 Arg2:T25	
R10	Has_index Arg1:T28 Arg2:T29	
R11	Has_temporal Arg1:T26 Arg2:T28	
R12	Has_negation Arg1:T26 Arg2:T27	
R13	Has_qualifier Arg1:T31 Arg2:T32	
R14	Has_index Arg1:T33 Arg2:T34	
*	OR T30 T31
R15	Has_negation Arg1:T30 Arg2:T36	
R16	Has_temporal Arg1:T30 Arg2:T33	
*	OR T38 T39 T40
R17	AND Arg1:T43 Arg2:T44	
R18	AND Arg1:T42 Arg2:T44	
R19	Has_negation Arg1:T42 Arg2:T45	
R20	Has_negation Arg1:T43 Arg2:T45	
*	OR T47 T48
R21	Has_negation Arg1:T46 Arg2:T50	
R22	Has_temporal Arg1:T46 Arg2:T47	
*	OR T51 T52
R23	Has_temporal Arg1:T54 Arg2:T51	
R24	Has_negation Arg1:T54 Arg2:T55	
R25	Has_index Arg1:T58 Arg2:T59	
*	OR T57 T56
R26	Has_temporal Arg1:T57 Arg2:T58	
R27	Has_temporal Arg1:T57 Arg2:T62	
R28	Has_negation Arg1:T57 Arg2:T66	
R29	Has_index Arg1:T52 Arg2:T60	
T1	Undefined_semantics 0 211	Subjects were not to have a history or presence of significant cardiovascular, pulmonary, hepatic, renal, haematologic, gastrointestinal, endocrine, immunologic, dermatologic, neurologic, or psychiatric disease.
T2	Condition 284 297	schizophrenia
T3	Condition 305 322	psychotic illness
T4	Condition 324 351	severe personality disorder
T5	Undefined_semantics 305 322	psychotic illness
T6	Condition 353 363	depression
T7	Condition 386 406	psychiatric disorder
T8	Qualifier 374 385	significant
T9	Undefined_semantics 374 406	significant psychiatric disorder
T10	Observation 266 280	family history
T11	Temporal 243 250	history
T12	Observation 254 262	presence
T15	Measurement 473 496	systolic blood pressure
T16	Value 437 461	postural drop of 20 mmHg
T17	Temporal 497 509	at screening
T18	Temporal 587 620	90 days prior to study initiation
T19	Observation 538 579	participated in a previous clinical trial
T20	Context_Error 512 621	Subjects were not to have participated in a previous clinical trial within 90 days prior to study initiation.
T21	Procedure 649 663	donated plasma
T22	Temporal 664 704	within 90 days prior to study initiation
T23	Reference_point 688 704	study initiation
T24	Negation 637 640	not
T25	Negation 423 426	not
T26	Procedure 733 746	donated blood
T27	Negation 721 724	not
T28	Temporal 747 787	within 90 days prior to study initiation
T29	Reference_point 771 787	study initiation
T30	Observation 823 836	abnormal diet
T31	Observation 852 876	changes in eating habits
T32	Qualifier 840 851	substantial
T33	Temporal 877 917	within 30 days prior to study initiation
T34	Reference_point 901 917	study initiation
T36	Negation 804 807	not
T37	Drug 975 997	enzyme-altering agents
T38	Drug 999 1011	barbiturates
T39	Drug 1013 1027	phenothiazines
T40	Drug 1029 1039	cimetidine
T41	Temporal 1046 1089	within 30 days prior to or during the study
T42	Condition 1134 1150	hypersensitivity
T43	Condition 1154 1176	idiosyncratic reaction
T44	Drug 1184 1194	study drug
T45	Negation 1114 1116	no
T46	Drug 1247 1270	prescription medication
T47	Temporal 1271 1294;1305 1314	within 14 days prior to the study
T48	Temporal 1298 1314	during the study
T50	Negation 1232 1235	not
T51	Temporal 1374 1396;1407 1416	within 7 days prior to the study
T52	Temporal 1400 1416	during the study
T54	Drug 1346 1373	over-the-counter medication
T55	Negation 1331 1334	not
T56	Condition 1469 1479	drug abuse
T57	Condition 1458 1465;1474 1479	alcohol abuse
T58	Temporal 1480 1513	within 2 years prior to the study
T59	Reference_point 1504 1513	the study
T60	Reference_point 1407 1416	the study
T62	Temporal 1447 1454	history
T63	Condition 1551 1566	use of cannabis
T64	Negation 1572 1584	not excluded
T65	Grammar_Error 1572 1584	not excluded
T66	Negation 1433 1436	not
T67	Not_a_criteria 1514 1754	(subjects with a history of previous use of cannabis were not excluded unless they had used cannabis or cannabinoid based medicine within 30 days prior to study drug administration or were unwilling to abstain for the duration of the study)
